MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Stryker Corporation Retained Earnings 2011-2026 | SYK
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20.5 B | 18.5 B | 16.8 B | 14.8 B | 13.5 B | 12.5 B | 11.7 B | 10.8 B | 8.99 B | 8.84 B | 7.79 B | 7.56 B | 7.62 B | 7.33 B | 6.48 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.5 B | 6.48 B | 11.6 B |
Quarterly Retained Earnings Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20 B | 19.4 B | 18.9 B | 18.3 B | 17.8 B | 17.3 B | 15.9 B | 15.5 B | 15.1 B | 14.8 B | 14.5 B | - | 13.5 B | 13.5 B | 13.1 B | 12.9 B | 12.5 B | 12.5 B | 12.5 B | 12.5 B | 12.5 B | 11.7 B | 11.7 B | 11.7 B | 11.7 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 8.99 B | 8.99 B | 8.99 B | 8.99 B | 8.84 B | 8.84 B | 8.84 B | 8.84 B | 7.79 B | 7.79 B | 7.79 B | 7.79 B | 7.56 B | 7.56 B | 7.56 B | 7.56 B | 7.62 B | 7.62 B | 7.62 B | 7.62 B | 7.33 B | 7.33 B | 7.33 B | 7.33 B | 6.48 B | 6.48 B | 6.48 B | 6.48 B |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20 B | 6.48 B | 10.9 B |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 13.57 | -2.61 % | $ 2.04 B | USA |
 |
AxoGen
AXGN
|
-307 M | $ 31.83 | -2.06 % | $ 1.47 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M | USA |
 |
Bio-Rad Laboratories
BIO
|
7.42 B | $ 268.57 | -0.11 % | $ 7.58 B | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 6.47 | 1.25 % | $ 465 M |  Israel |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
-191 M | $ 14.88 | 2.27 % | $ 402 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.52 | -0.56 % | $ 122 M | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 39.42 | -0.88 % | $ 5.87 K | USA |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 74.81 | -0.45 % | $ 111 B | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.59 | 2.62 % | $ 171 M |  France |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
21.2 M | $ 23.49 | 1.47 % | $ 199 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 45.25 | -1.72 % | $ 1.4 B | USA |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
GBS
GBS
|
-62.5 M | - | -0.57 % | $ 7.12 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 14.01 | 0.21 % | $ 906 M | Israel |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 99.69 | 0.6 % | $ 1.26 B | USA |
 |
Delcath Systems
DCTH
|
-532 M | $ 10.01 | 0.55 % | $ 285 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
LivaNova PLC
LIVN
|
-903 M | $ 68.0 | -1.52 % | $ 3.69 B |  Britain |
 |
Establishment Labs Holdings
ESTA
|
-445 M | $ 80.73 | 1.33 % | $ 2.27 B |  Costa-rica |
 |
Invacare Corporation
IVC
|
-78.4 M | - | - | $ 24.7 M | USA |
 |
Myomo
MYO
|
-88.8 M | $ 0.73 | 13.17 % | $ 5.15 M | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.55 | -0.11 % | $ 122 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
-374 M | $ 2.4 | -1.03 % | $ 141 M | Israel |
 |
Orthofix Medical
OFIX
|
-368 M | $ 12.99 | 1.88 % | $ 514 M |  Curacao |
 |
Pulmonx Corporation
LUNG
|
-468 M | $ 1.62 | 6.95 % | $ 63.4 M | USA |
 |
Globus Medical
GMED
|
1.39 B | $ 94.67 | 3.01 % | $ 12.8 B | USA |
 |
Insulet Corporation
PODD
|
287 M | $ 246.43 | 0.48 % | $ 17.3 B | USA |